CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Planned sale Chief Commercial Officer sold 1,958 shares at an average $553.11 ($1,082,986)
- 4 Planned sale Director sold 8,500 shares at an average $520.96 ($4,428,198)
- 4 Open-market sale Director sold 16,575 shares at an average $484.30 ($8,027,354)
- 4 Open-market sale President and CEO sold 7,279 shares at $445.63 ($3,243,741)
- 4 Planned sale President and CEO sold 7,616 shares at an average $400.18 ($3,047,756)
- 4 Open-market buy Director bought 97,065 shares at an average $380.58 ($36,941,197)
- 4 Open-market buy Director bought 68,618 shares at an average $364.04 ($24,979,827)
- 4 Planned sale General Counsel sold 1,304 shares at an average $367.81 ($479,627)
- 4 Open-market sale Director sold 10,000 shares at an average $365.20 ($3,652,009)
- 4 Planned sale Director sold 129,172 shares at an average $370.24 ($47,825,149)
- 4 Planned sale Director sold 46,808 shares at an average $355.31 ($16,631,386)
- 4 Planned sale Director sold 46,463 shares at an average $355.32 ($16,509,032)
- 4 Grant or award Director acquired 967 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 1,000 shares at $350.01 ($350,005)
- 4 Planned sale Director sold 1,400 shares at $350.03 ($490,044)
- 4 Planned sale Director sold 28,876 shares at an average $353.19 ($10,198,844)
- 4 Planned sale Director sold 29,101 shares at an average $353.19 ($10,278,098)
- 4 Grant or award Director acquired 715 shares (grant or award)
- 4 Grant or award Director acquired 715 shares (grant or award)
Page 3 of 29 · 564 filings